A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid-Reference-Cited by-同舟云学术

A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid

Published:2017-02 Issue:2 Volume:85 Page:77-84
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Amagai Masayuki,Ikeda Shigaku,Hashimoto Takashi,Mizuashi Masato,Fujisawa Akihiro,Ihn Hironobu,Matsuzaki Yasushi,Ohtsuka Mikio,Fujiwara Hiroshi,Furuta Junichi,Tago Osamu,Yamagami Jun,Tanikawa Akiko,Uhara Hisashi,Morita Akimichi,Nakanishi Gen,Tani Mamori,Aoyama Yumi,Makino Eiichi,Muto Masahiko,Manabe Motomu,Konno Takayuki,Murata Satoru,Izaki Seiichi,Watanabe Hideaki,Yamaguchi Yukie,Matsukura Setsuko,Seishima Mariko,Habe Koji,Yoshida Yuichi,Kaneko Sakae,Shindo Hajime,Nakajima Kimiko,Kanekura Takuro,Takahashi Kenzo,Kitajima Yasuo,Hashimoto Koji

Funder

Bell Medical Solutions, Inc., Tokyo, Japan

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference22 articles.

1. British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012;Venning;Br. J. Dermatol.,2012

2. Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology;Mydlarski;J. Cutan. Med. Surg.,2006

3. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases;Ahmed;Arch. Dermatol.,2003

4. Criteria for the Clinical Use of Intravenous Immunoglobulin in Australia,2012

5. Guidelines on the use of high-dose intravenous immunoglobulin in dermatology;Enk;Eur. J. Dermatol.,2009

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease;Drugs & Therapy Perspectives;2024-07-05

2. Neonatal Fc Receptor Inhibition Reduces Bullous Pemphigoid Anti–Basement Membrane Zone IgG Deposition and Blistering in 3-Dimensional Human Skin Equivalents;Journal of Investigative Dermatology;2024-06

3. Immunobullous Diseases;Rook's Textbook of Dermatology;2024-03-19

4. Role of regulatory T cells in pathogenesis and therapeutics of pemphigus vulgaris and bullous pemphigoid;Regulatory T Cells and Autoimmune Diseases;2024

5. Bullous pemphigoid induced by IgG targeting type XVII collagen non‐NC16A/NC15A extracellular domains is driven by Fc gamma receptor‐ and complement‐mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade;The Journal of Pathology;2023-11-06